However, much work remains, and continued research with larger well-defined study subjects with associated clinical correlates, with additionally discovered variants that have been characterized in biological assays, will elucidate the role of BARD1 in the etiology of cancer and help develop guidelines for care in carriers and new therapies. The gene discussed is BARD1; the disease is cancer.